AstraZeneca PLC - Directorate Change - view original
AstraZeneca PLC | Reg No. 02723534 | SIC Code 2441 | HQ London | Tel 0207 3045000 | Turnover £20,313.0m | Employees 66600 | Locations 22 | 95 Company Alerts | 14 Subsidiary Alerts
AZN - NEW NON-EXECUTIVE DIRECTOR AstraZeneca today announced that Dr Bruce Burlington is to join the Board of Directors as a Non-Executive Director, with effect from 1 August 2010. Dr Burlington will also become a member of the Board's Science Committee. Dr Burlington spent 17 years of his ...
29 Jul 2010
Strong quarter for AstraZeneca as FDA panel backs Brilinta - view original
AstraZeneca PLC | Reg No. 02723534 | SIC Code 2441 | HQ London | Tel 0207 3045000 | Turnover £20,313.0m | Employees 66600 | Locations 22 | 95 Company Alerts | 14 Subsidiary Alerts
AstraZeneca shares are on the rise this morning after the firm posted a strong set of financials for the second quarter and celebrated a recommendation for approval from US advisory panel for its bloo...
AstraZeneca PLC | Reg No. 02723534 | SIC Code 2441 | HQ London | Tel 0207 3045000 | Turnover £20,313.0m | Employees 66600 | Locations 22 | 95 Company Alerts | 14 Subsidiary Alerts
Turning to larger companies AstraZeneca is a strong performer. The group’s potential blockbuster heart drug Brilinta has received the backing of a US advisory panel.
29 Jul 2010
AstraZeneca ups guidance as profits rise | Digital Look - view original
AstraZeneca PLC | Reg No. 02723534 | SIC Code 2441 | HQ London | Tel 0207 3045000 | Turnover £20,313.0m | Employees 66600 | Locations 22 | 95 Company Alerts | 14 Subsidiary Alerts
Pharmaceutical giant AstraZeneca had a double dose of good news today as it jumped up the FTSE100 after raising its forecasts for full-year core earnings to between $6.35 and $6.65 a share, up from Ap...
29 Jul 2010
AstraZeneca PLC - Second Quarter and Half Year Results (Part 1 of 3)
29 Jul 2010
Antisoma's preliminary results for the year ended 30 June 2010
29 Jul 2010
Vernalis Plc - Interim results for six months ended 30 June 2010
28 Jul 2010
Teva earnings soar yet again, driven by Copaxone
28 Jul 2010
Proximagen Group PLC - Half Yearly Report
28 Jul 2010
Cussons in a froth as Imperial Leather maker posts raised profits
27 Jul 2010
Israel-based company Teva Pharmaceuticals has reported an increase in profit of 53 per cent for the ...
27 Jul 2010
Calibra Gains FDA Clearance To Market Finessea Insulin Patch-Pen For Three-Day Use With Novolog
27 Jul 2010
Calibra Gains FDA Clearance To Market Finesse Insulin Patch-Pen For Three-Day Use With Novolog®
27 Jul 2010
GW Pharmaceuticals Plc - Directorate Change
27 Jul 2010
PZ Cussons PLC - Final Results
26 Jul 2010
Comments
26 Jul 2010
UPDATE: GlaxoSmithKline Pharmaceuticals 2Q Net Profit Rises 4%
26 Jul 2010
Just one new approval in latest EMA opinions, generic Cellcept OK
23 Jul 2010
Neurovascular Disease: Gladstone And Lundbeck Collaboration Will Identify Novel Therapeutic Strategi...
23 Jul 2010
Q2 sales, profit improve for 3 major drugmakers
22 Jul 2010
Bristol-Myers Squibb (BMS) has reported a drop in second-quarter profit that the company attributes ...
22 Jul 2010
Abbott Laboratories has reported an unchanged net profit for the second quarter of 2010
22 Jul 2010
Eli Lilly 2Q Profit Rises 16%; Bristol-Myers Profit Down 5.7%
22 Jul 2010
CORRECT: Eli Lilly 2Q Profit Jumps 16% On Higher Revenue;EPS View Raised
22 Jul 2010
UPDATE: Eli Lilly 2Q Profit Jumps 16% On Higher Revenue;EPS View Raised
22 Jul 2010
Eli Lilly 2Q Profit Jumps 16% On Higher Revenue;EPS View Raised
22 Jul 2010
Allergy Therapeutics PLC - Trading Statement
22 Jul 2010
SSL International Plc - Result of AGM
22 Jul 2010
Abbott sales climb, plots further growth in emerging markets
22 Jul 2010
Roche half-year profit rises 37 percent to $5.3B
22 Jul 2010
Glaxo sees us sales stall
21 Jul 2010
Glaxo's 2Q Tops Expectations
21 Jul 2010
GSK struck down with US sales fall
21 Jul 2010
GlaxoSmithKline struggles to get past US sales slump
29 Jul 2010
29 Jul 2010
|